Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Tranexamic Acid for Second Trimester Dilation and Evacuation
NCT06820177Phase 4Recruiting
- Sponsor
- University of California, San Diego
- Start
- Apr 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemorrhage comparing Placebo with Tranexamic acid (2 arms). Primary endpoint: Composite outcome of excessive bleeding. Started Apr 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06820177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06820177.